Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Non-cash Items (2023 - 2025)

Cardiff Oncology's Non-cash Items history spans 8 years, with the latest figure at $2.7 million for Q4 2025.

  • For Q4 2025, Non-cash Items fell 77.05% year-over-year to $2.7 million; the TTM value through Dec 2025 reached $2.7 million, down 77.05%, while the annual FY2025 figure was $2.7 million, 77.05% down from the prior year.
  • Non-cash Items for Q4 2025 was $2.7 million at Cardiff Oncology, up from $759735.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $13.7 million in Q2 2025 and bottomed at $23926.0 in Q4 2023.
  • The 3-year median for Non-cash Items is $8.1 million (2024), against an average of $7.1 million.
  • The largest annual shift saw Non-cash Items skyrocketed 48671.17% in 2024 before it tumbled 90.62% in 2025.
  • A 3-year view of Non-cash Items shows it stood at $23926.0 in 2023, then surged by 48671.17% to $11.7 million in 2024, then tumbled by 77.05% to $2.7 million in 2025.
  • Per Business Quant, the three most recent readings for CRDF's Non-cash Items are $2.7 million (Q4 2025), $759735.0 (Q3 2025), and $13.7 million (Q2 2025).